Seppo Kaakkola

Affiliations: 
University of Helsinki, Helsingfors, Finland 
Area:
neurology
Google:
"Seppo Kaakkola"
Mean distance: 14.64 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Scheperjans F, Pekkonen E, Kaakkola S, et al. (2015) Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota? Journal of Parkinson's Disease
Scheperjans F, Aho V, Pereira PA, et al. (2015) Gut microbiota are related to Parkinson's disease and clinical phenotype. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 350-8
Pasanen P, Myllykangas L, Siitonen M, et al. (2014) Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiology of Aging. 35: 2180.e1-5
Kaakkola S, Tuominen R. (2013) [Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties]. Duodecim; LääKetieteellinen Aikakauskirja. 129: 1654-60
Kaakkola S, Onarheim KJ. (2012) Continuous dopaminergic stimulation - The evolving management of advanced Parkinson's disease European Neurological Review. 7: 3-4
Kaakkola S. (2010) Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's disease. International Review of Neurobiology. 95: 207-25
Kuoppamäki M, Korpela K, Marttila R, et al. (2009) Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily. European Journal of Clinical Pharmacology. 65: 443-55
Kičić D, Bikmullina R, Lioumis P, et al. (2007) Effects of 10 Hz rTMS on spontaneous brain oscillations in non-demented Parkinson's patients: Preliminary results of combined MEG-rTMS study International Congress Series. 1300: 717-720
Myllylä V, Haapaniemi T, Kaakkola S, et al. (2006) Patient satisfaction with switching to Stalevo: an open-label evaluation in PD patients experiencing wearing-off (Simcom Study). Acta Neurologica Scandinavica. 114: 181-6
Eerola J, Tienari PJ, Kaakkola S, et al. (2005) How useful is [123I]beta-CIT SPECT in clinical practice? Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1211-6
See more...